XML 100 R52.htm IDEA: XBRL DOCUMENT v3.20.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2019
STOCK-BASED COMPENSATION  
Schedule of pre-tax expense associated with stock options and restricted stock awards and related benefit

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

2019

 

2018

 

2017

 

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

Employee compensation expense:

 

 

 

 

 

 

 

 

 

Stock options

  

$

1,213

 

$

694

 

$

600

Restricted stock awards

 

 

2,204

 

 

2,360

 

 

895

Directors' fee expense:

 

 

 

 

 

 

 

 

 

Stock options

 

 

572

 

 

629

 

 

246

Restricted stock awards

 

 

860

 

 

910

 

 

355

Total stock-based compensation expense

 

$

4,849

 

$

4,593

 

$

2,096

Related tax benefits recognized in earnings

 

$

1,042

 

$

965

 

$

589

 

Schedule of stock options, valuation assumptions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

 

2019

 

2018

 

 

2017

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

583,565

 

 

289,890

 

 

1,585,924

 

Vesting period (years)

 

 

3

 

 

3

 

 

3

 

Term (years)

 

 

10

 

 

10

 

 

10

 

Weighted average expected volatility

 

 

22.09

%

 

22.16

%

 

24.00

%

Expected life (years)

 

 

6

 

 

6

 

 

6

 

Expected dividend yield

 

 

 —

%

 

 —

%

 

 —

%

Weighted average risk free interest rate

 

 

2.46

%

 

2.93

%

 

1.88

%

Weighted average fair value per option

 

 

$
2.49

 

 

$
2.83

 

 

$
2.82

 

 

Schedule of stock option activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding

 

Nonvested

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

Weighted

 

 

 

 

Weighted

 

Remaining

 

Aggregate

 

 

 

Average

 

 

Stock Option

 

Average

 

Contractual

 

Intrinsic

 

Stock Option

 

Grant Date

 

 

Awards

 

Exercise Price

 

Term (years)

 

Value

 

Awards

 

Fair Value

 

 

 

 

 

  

 

 

  

 

  

 

 

  

 

 

 

  

 

Balance at January 1, 2019

  

  

1,778,407

  

$

10.17

  

 

 

  

 

 

  

 

1,249,793

  

$

2.82

Granted

 

 

583,565

 

 

9.09

 

 

 

 

 

 

 

 

583,565

 

 

2.49

Vested

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(555,622)

 

 

2.83

Forfeited

 

 

(81,191)

 

 

10.20

 

 

 

 

 

 

 

 

(81,191)

 

 

2.81

Expired

 

 

(111,538)

 

 

10.23

 

 

 

 

 

 

 

 

 —

 

 

 —

Balance at December 31, 2019

 

 

2,169,243

 

$

9.87

 

 

8.20

 

$

2,419,000

 

 

1,196,545

 

$

2.66

Exercisable at December 31, 2019

 

 

972,698

 

$

10.19

 

 

7.80

 

$

 —

 

 

 

 

 

 

Unrecognized cost inclusive of directors' awards

 

$

2,321,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining recognition period (years)

 

 

1.61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of non-vested stock award activity

 

 

 

 

 

 

 

 

 

Restricted

 

Weighted Average

 

 

Stock Awards

 

Grant Price

 

 

 

 

 

 

 

Non-vested stock awards at January 1, 2019

 

 

617,293

 

$

10.24

Vested

 

 

(298,484)

 

 

10.23

Granted

 

 

47,276

 

 

9.94

Forfeited

 

 

(32,319)

 

 

10.20

Non-vested stock awards at December 31, 2019

 

 

333,766

 

$

10.20

Unrecognized cost inclusive of directors' awards

 

$

2,217,000

 

 

 

Weighted average remaining recognition period (years)

 

 

0.92